What top creators are saying about Genmab A/S(GMAB)

Biotechnology company focused on antibody therapeutics, including cancer treatments

2 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Based on 2 scored insights about Genmab A/S.

Strongly bullish
avg +0.60
2 bullish0 neutral0 bearish

Top creators covering Genmab A/S (GMAB)

The 2 sources with the most insights about Genmab A/S on Kazuha.

Latest insights about Genmab A/S (GMAB)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Yesterday

Bullish

The speaker called Genmab's result incredible and expressed interest in examining the company further, but provided no specific recommendation or detailed investment analysis.

Very Bullish

The speaker called Genmab incredible and a significant cancer-focused player, describing it as a more established or substantive opportunity than Moderna.

Discussed alongside Genmab A/S (GMAB)

Other assets that creators frequently mention in the same content as Genmab A/S.

Frequently asked

Which podcasters and creators cover Genmab A/S (GMAB) the most?

The most active sources covering Genmab A/S (GMAB) on Kazuha are @realmartinshkreli, @shkreliplanet. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Genmab A/S (GMAB) are on Kazuha?

Kazuha has indexed 2 AI-extracted insights about Genmab A/S (GMAB) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Genmab A/S (GMAB)?

Creators covering Genmab A/S (GMAB) most frequently also discuss LLY, GOOGL, MRNA, SNDK, AMZN. See the "Discussed alongside" section above for full asset pages.